Our data show that Hsp90 is necessary to maintain adequate levels of REST and mHtt, which suggests that the interaction between Hsp90-REST and Hsp90-Huntingtin could be a potential therapeutic target for treating Huntington's disease. This evidence concerns the gene HSP90AB1 and Huntington disease.